NCT00051896Unknown1 期
Double-Blind, Placebo-Controlled, Dose Escalating, Safety and Pharmacology Study With Three Dosages of GBR 12909 in Cocaine Experienced Volunteers
适应症
相关药物
试验速览
- 阶段
- 1 期
- 入组人数
- 24
- 试验地点
- 2
- 主要终点
- Pharmacokinetic parameter comparison
研究概览
简要总结
The purpose of this study is to assess the potential interactions between iv cocaine and GBR 12909.
详细描述
This is a single dose with escalation, double-blind, placebo-controlled inpatient study in which 24 cocaine experienced volunteers that meet protocol eligibility criteria during a 30 day screen period will be randomized into three dose groups.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 45 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Must understand study procedures and provide written informed consent
- •For additional inclusion criteria information, please contact study site for more information.
排除标准
- •Please contact study site for more information.
结局指标
主要结局
Pharmacokinetic parameter comparison
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
Unknown
1 期
Assessment of Potential Interactions Between GBR 12909 and Cocaine - 1Cocaine-Related DisordersNCT00100113National Institute on Drug Abuse (NIDA)24
已完成
1 期
Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine - 1Cocaine-Related DisordersNCT00265265National Institute on Drug Abuse (NIDA)16
终止
1 期
Interactions Between Intravenous (IV) Cocaine and LofexidineCocaine Related DisordersNCT01148992National Institute on Drug Abuse (NIDA)16
已完成
2 期
Pharmacological Modulation of Cocaine Effects - 1Cocaine-Related DisordersNCT00000201National Institute on Drug Abuse (NIDA)
Unknown
1 期
GBR 12909 Study in Cocaine Experienced African American Volunteers - 1Cocaine-Related DisordersNCT00089687National Institute on Drug Abuse (NIDA)10